Trademark: 88066252
Word
AESKUCARE
Status Date
Monday, June 17, 2024
Filing Date
Monday, August 6, 2018
5 Medical, chemical and biological test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing for medical purposes, and test reagents, namely, genetic identity tests comprised of reagents for medical purposes; Antiserums for diagnostic purposes; Chemical reagents for medical diagnostic, medical or veterinary purposes; Medical or veterinary chemical test reagents for medical use; Chemical test reagents for medical use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical and veterinary purposes; Diagnostic preparations for medical, pharmaceutical or veterinary purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic testing materials for medical use, namely, medical diagnosis test strips for blood analysis or bodily fluids analysis; Diagnostic reagents for medical use; Diagnostic substances for medical use; Immunoassay reagents for medical or medical diagnostic purposes; In vitro diagnostic preparations for medical use; Indicators for medical diagnosis, namely, diagnostic preparations for medical purposes; Medical diagnostic test strips for blood analysis or bodily fluids analysis; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents; Preparations of microorganisms for medical or veterinary use; Preparations for detecting genetic predispositions for medical purposes; Preparations for detecting mutation in prion genes for medical purposes; Chemical reagents for use in analysis for veterinary purposes; Chemical reagents for analysis purposes for medical diagnostic, medical or veterinary purposes; Reagents for use in diagnostic tests comprised of veterinary diagnostic reagents; Diagnostic reagents for in-vitro laboratory use for medical purposes; Diagnostic reagents for in-vitro laboratory use for veterinary purposes; Diagnostic reagents for blood grouping for medical purposes; Medical diagnostic reagents for use with testing apparatus for testing of blood analysis or bodily fluids analysis for autoimmune diseases, neurological diseases or cancer for medical or medical diagnostic purposes; Diagnostic reagents for use in diagnostic tests and analyses for testing and analysis of blood or bodily fluids for autoimmune diseases, neurological diseases or cancer for medical purposes; Diagnostic reagents for use with testing apparatus for testing of blood or bodily fluids for autoimmune diseases, neurological diseases or cancer for medical diagnostic or veterinary purposes; Reactants for medical or veterinary diagnosis, namely, diagnostic reagents for medical and veterinary uses; Veterinary diagnostic reagents; Clinical medical reagents; Biological reagents for medical, medical diagnostic and veterinary purposes; Chemical reagents for medical, medical diagnostic and veterinary purposes; Chemical reagents for medical and veterinary purposes; Reagents for microbiological analysis, for medical or veterinary purposes; Genetic identity tests, consisting of reagents for medical purposes; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Reagents for medical and veterinary genetic testing; Chemical preparations for use in DNA analysis for medical use; Chemical preparations for medical and medical diagnostic purposes, namely, for autoimmune diseases, neurological diseases or cancer; Blood for medical purposes, and blood plasma for medical diagnostic purposes; Biological preparations for medical, medical diagnostic and veterinary purposes for the treatment of autoimmune diseases, neurological diseases or cancer; Mixed biological preparations for medical and medical diagnostic purposes for the prevention and treatment of infectious diseases; Blood plasma; Blood components, namely, platelet rich blood plasma and stem cells for medical use; Blood protein fractions, namely, blood plasma fractions or bodily fluid fractions for medical diagnostic purposes and medical therapeutic purposes; Enzymes for medical, medical diagnostic and veterinary purposes; Enzyme preparations for medical and veterinary purposes; By-products of the processing of cereals for medical and medical diagnostic purposes; Nucleic acid sequences for medical diagnostic, medical and veterinary purposes
1 Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical use; Diagnostic reagents for in-vitro clinical laboratory use
The wording "AESKUCARE" has no meaning in a foreign language.
Sep 12, 2018
Non-Final Action Written
Aug 9, 2018
New Application Entered
Aug 10, 2018
New Application Office Supplied Data Entered
Sep 11, 2018
Assigned To Examiner
Sep 12, 2018
Non-Final Action E-Mailed
Sep 12, 2018
Notification Of Non-Final Action E-Mailed
Sep 13, 2018
Non-Final Action Written
Sep 13, 2018
Non-Final Action E-Mailed
Sep 13, 2018
Notification Of Non-Final Action E-Mailed
Mar 8, 2019
Teas Response To Office Action Received
Mar 11, 2019
Assigned To Lie
Mar 13, 2019
Correspondence Received In Law Office
Mar 13, 2019
Teas/Email Correspondence Entered
Mar 30, 2019
Suspension Letter Written
Mar 30, 2019
Letter Of Suspension E-Mailed
Mar 30, 2019
Notification Of Letter Of Suspension E-Mailed
Oct 7, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 7, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 9, 2019
Suspension Checked - To Attorney For Action
Oct 9, 2019
Suspension Inquiry Written
Oct 9, 2019
Inquiry To Suspension E-Mailed
Oct 9, 2019
Notification Of Inquiry As To Suspension E-Mailed
Apr 2, 2020
Teas Response To Suspension Inquiry Received
Apr 7, 2020
Correspondence Received In Law Office
Apr 7, 2020
Teas/Email Correspondence Entered
Apr 10, 2020
Suspension Letter Written
Apr 10, 2020
Letter Of Suspension E-Mailed
Apr 10, 2020
Notification Of Letter Of Suspension E-Mailed
Nov 10, 2020
Suspension Checked - To Attorney For Action
Nov 24, 2020
Suspension Inquiry Written
Nov 24, 2020
Inquiry To Suspension E-Mailed
Nov 24, 2020
Notification Of Inquiry As To Suspension E-Mailed
Apr 22, 2021
Teas Response To Suspension Inquiry Received
May 5, 2021
Correspondence Received In Law Office
May 5, 2021
Teas/Email Correspondence Entered
May 5, 2021
Suspension Letter Written
May 5, 2021
Letter Of Suspension E-Mailed
May 5, 2021
Notification Of Letter Of Suspension E-Mailed
Nov 8, 2021
Suspension Checked - To Attorney For Action
Nov 15, 2021
Assigned To Examiner
Nov 16, 2021
Suspension Inquiry Written
Nov 16, 2021
Inquiry To Suspension E-Mailed
Nov 16, 2021
Notification Of Inquiry As To Suspension E-Mailed
May 11, 2022
Teas Response To Suspension Inquiry Received
May 24, 2022
Correspondence Received In Law Office
May 24, 2022
Teas/Email Correspondence Entered
May 24, 2022
Suspension Letter Written
May 24, 2022
Letter Of Suspension E-Mailed
May 24, 2022
Notification Of Letter Of Suspension E-Mailed
Nov 21, 2022
Suspension Letter Written
Nov 21, 2022
Letter Of Suspension E-Mailed
Nov 21, 2022
Notification Of Letter Of Suspension E-Mailed
May 22, 2023
Report Completed Suspension Check Case Still Suspended
Nov 20, 2023
Suspension Inquiry Written
Nov 20, 2023
Inquiry To Suspension E-Mailed
Nov 20, 2023
Notification Of Inquiry As To Suspension E-Mailed
Feb 19, 2024
Teas Response To Suspension Inquiry Received
Jun 17, 2024
Letter Of Suspension E-Mailed
Jun 17, 2024
Notification Of Letter Of Suspension E-Mailed
Jun 17, 2024
Teas/Email Correspondence Entered
Jun 17, 2024
Suspension Letter Written
Jun 17, 2024
Correspondence Received In Law Office
Jun 17, 2024
Assigned To Lie
Trademark Alertz updated from USPTO on 2030-01-24
